Arlington Capital purchases majority stake in Riverpoint Medical
Arlington Capital Partners has purchased a majority stake in US-based medical devices maker Riverpoint Medical.
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
Arlington Capital Partners has purchased a majority stake in US-based medical devices maker Riverpoint Medical.
NHS adopts HeartFlow's AI software that generates a digital 3D model of the heart to help reduce misdiagnosis…
Italian firm Bracco Imaging has agreed to acquire UK-based molecular imaging company Blue Earth Diagnostics from Syncona for…
Digital Therapeutics in healthcare need its lack of funding to be addressed as it has the potential to…
US-based InterVene has secured $15m (£11.7m) series B funding for first catheter-based system to correct deep vein valve…
By providing a virtual treatment method for stroke patients, Visionable helps clinicians across NHS organisations save thousands of…
The showcase of UK’s first remote ultrasound scan demonstrated how 5G will support digital transformation in the delivery…
Allergan has secured approval from the US Food and Drug Administration (FDA) for its CoolTone device to improve…
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health has undertaken significant steps to…
Cleveland Clinic has projects underway to prevent burnout among its staff by integrating AI in healthcare, which will…